Health-related quality of life in patients with moderate to severe psoriasis: Effects of treatment with ABT-874 versus etanercept or placebo

被引：0
作者：
Crowley, Jeffrey [1 ]
Yang, Hongbo [2 ]
Sundaram, Murali [3 ]
Mulani, Parvez [3 ]
机构：
[1] Bakersfield Dermatol, Bakersfield, CA USA
[2] Anal Grp, Boston, MA USA
[3] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2011年 / 64卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB160 / AB160
页数：1
相关论文
共 50 条
[31]   Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis [J].
Feldman, S. R. ;
Gottlieb, A. B. ;
Bala, M. ;
Wu, Y. ;
Eisenberg, D. ;
Guzzo, C. ;
Li, S. ;
Dooley, L. T. ;
Menter, A. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (03) :704-710
[32]   USTEKINUMAB IS ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN OVERALL HEALTH-RELATED QUALITY OF LIFE IN MODERATE-TO-SEVERE PSORIASIS PATIENTS [J].
Schenkel, B. ;
Langley, R. ;
Wang, Y. ;
Kimball, A. .
VALUE IN HEALTH, 2009, 12 (07) :A528-A528
[33]   The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease [J].
Sands, Bruce E. ;
Han, Chenglong ;
Gasink, Christopher ;
Jacobstein, Douglas ;
Szapary, Philippe ;
Gao, Long-Long ;
Lang, Yinghua ;
Targan, Stephan ;
Sandborn, William J. ;
Feagan, Brian G. .
JOURNAL OF CROHNS & COLITIS, 2018, 12 (08) :883-895
[34]   Ustekinumab improves disease specific health-related quality of life in patients with moderate to severe psoriasis: Results with the dermatology life quality index [J].
Lebwohl, M. ;
Papp, K. ;
Schenkel, B. ;
Eisenberg, D. ;
Yeilding, N. ;
Guzzo, C. ;
Wang, Y. ;
Li, S. ;
Krueger, G. G. .
VALUE IN HEALTH, 2008, 11 (03) :A293-A293
[35]   Psoriasis patients show improved health-related quality of life when treated with etanercept (ENBREL) [J].
Wanke, LA ;
Gottlieb, AB ;
Lowe, NJ ;
Lebsack, ME .
ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :S120-S120
[36]   Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis [J].
Chung, Jina ;
Duffin, Kristina Callis ;
Takeshita, Junko ;
Shin, Daniel B. ;
Krueger, Gerald G. ;
Robertson, Andrew D. ;
Troxel, Andrea B. ;
Van Voorhees, Abby S. ;
Edson-Heredia, Emily ;
Gelfand, Joel M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (04) :623-632
[37]   The impact of ixekizumab treatment on health-related quality of life in patients with moderate-to-severe psoriasis: results from UNCOVER-1 [J].
Augustin, M. ;
Gordon, K. ;
Nikai, E. ;
Edson-Heredia, E. ;
Zhu, B. ;
Goldblum, O. M. ;
Carlier, H. ;
Langley, R. G. .
EXPERIMENTAL DERMATOLOGY, 2016, 25 (03) :E9-E9
[38]   Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases [J].
James W. Varni ;
Denise R. Globe ;
Shravanthi R. Gandra ;
David J. Harrison ;
Michele Hooper ;
Scott Baumgartner .
European Journal of Pediatrics, 2012, 171 :485-492
[39]   Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis [J].
Revicki, Dennis A. ;
Willian, Mary K. ;
Menter, Alan ;
Saurat, Jean-Hilaire ;
Harnam, Neesha ;
Kaul, Martin .
DERMATOLOGY, 2008, 216 (03) :260-270
[40]   Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases [J].
Varni, James W. ;
Globe, Denise R. ;
Gandra, Shravanthi R. ;
Harrison, David J. ;
Hooper, Michele ;
Baumgartner, Scott .
EUROPEAN JOURNAL OF PEDIATRICS, 2012, 171 (03) :485-492
12345